Charles W. Bourque, McGill University, Montreal, QC, Canada, ‘Clock Neurons, Glial cells and osmoregulated firing by vasopressin neurons’
Harold Gainer, NINDS, Bethesda, MD, USA, ‘Cell-specific expression of oxytocin and vasopressin genes: An experimental odyssey’
Jolanta Gutkowska, McGill University, Montreal, QC, ‘Oxytocin revisited; its role in cardiovascular regulation’
Maurice Manning, The University of Toledo, Toledo, OH, USA, ‘Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics’
Inga D. Neumann, University of Regensburg, Regensburg, Germany, ‘Brain oxytocin and vasopressin: mediators of stress, emotions and social behaviours’
Tatsushi Onaka, Jichi Medical School, Shimotsuke, Tochigi, Japan, ‘Role of oxytocin in the control of social recognition’
John A. Russell, University of Edinburgh, Edinburgh, UK, ‘Oxytocin and vasopressin cells: unsurpassed model neuroendocrine neurons’
Celia Sladek, University of Colorado Denver, CO, USA, ‘Neurotransmitter and Hormonal Regulation of Vasopressin and Oxytocin Secretion’
SYMPOSIA
Oxytocin, Social Cognition, and Behavior: Organizer: Larry Young, Emory University, USA
Young Investigators Symposium: Organizer: Heather Caldwell, Kent State University, USA
Translational Directions of Current Oxytocin Research: Organizer: Robert Ring, Pfizer, USA
Genetic Models for Neurohypophyseal Development and Function: Organizer: Gil Levkowitz,Weizmann Institute, Israel
Clinical Use of Vasopressin Receptor Antagonists in Hyponatremia: The Science of Who We Should Treat, and Why’: Organizer: Joseph Verbalis, Georgetown University, USA
The Hypothalamo-Neurohypophyseal System: from Genome to Physiology: Organizer: David Murphy, University of Bristol, UK
Glial Control of Magnocellular Neurons: Organizer: Colin Brown, University of Otago, New Zealand
Keynote 1(5:45 – 6:30) – John A. Russell, University of Edinburgh, Edinburgh, UKL: ‘Oxytocin and vasopressin cells: unsurpassed model neuroendocrine neurons’
Welcoming Reception(6:30 – 8:30)
THURSDAY
Symposium 1(8:15 – 10:15):‘Oxytocin, Social Cognition, and Behavior’
Organizer and Chair:
Larry Young, Emory University, USA
Speakers:
Ruth Feldman, Bar-Ilan University, Israel: ‘Oxytocin and affiliation in humans: Becoming a parent and falling in love’
René Hurlemann, University of Bonn, Germany:‘Oxytocin closes gender gap in socially reinforced learning and emotional empathy’
Adam Guastella, University of Sydney:‘Oxytocin and processing of social information in healthy and clinical population’
Coffee Break(10:15 – 10:45)
Keynote 2(10:45 – 11:30) — Tatsushi Onaka, Jichi Medical School, Shimotsuke, Tochigi, Japan:‘Role of oxytocin in the control of social recognition’
Michael Bowen, University of Sydney: ‘Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats’
Kimberly Young, Florida State University: ‘Oxytocin Reverses Amphetamine-Induced Social Deficits in the Monogamous Prairie Vole’
Benjamin F. Rood, Children’s Hospital of Philadelphia: ‘Vasopressin alters Post-Synaptic Current Activity in Serotonin Neurons of the Dorsal Raphe’
Katrina Choe, McGill University: ‘Salt-Loading reverses Chloride Gradient via Downregulation of KCC 2 In Rat Supraoptic Neurons’
Thekkethil P. Nedungadi, University of North Texas Health Science Center: ‘Expression and Regulation of TRPV2 in Rat Magnocellular Neurosecretory Cells’
Victoria Scott, University of Otago: ‘Hormonal Activation of Oxytocin and Vasopressin Neurons by Peripheral Kisspeptin’
Zoe Donaldson, Columbia University: ‘Microsatellite Regions upstream of the Vole Avpr1a Gene contribute to both Individual and Species Differences in Receptor Expression’
Sophie Knobloch, Max Planck Institute, Heidelberg: ‘Monosynaptic Connections of Oxytocin, but not Vasopressin Neurons in the Hypothalamus of Lactating Rats’
Keynote 3(5:15 – 6:00) — Celia Sladek, University of Colorado Denver, CO, USA: ‘Neurotransmitter and Hormonal Regulation of Vasopressin and Oxytocin Secretion’
Special Lecture(6:00 – 6:30) — Jolanta Gutkowska, McGill, Canada: ‘Oxytocin revisited; its role in cardiovascular regulation’
FRIDAY
Symposium 3(8:15 – 10:15):‘Translational Directions of Current Oxytocin Research’
Organizer:
Robert Ring, Pfizer, USA
Speakers:
David Feifel, UC San Diego, USA: ‘Oxytocin as a putative therapeutic agent for schizophrenia’
Simon Gregory, Duke U, USA: ‘Epigenetic Evidence of Oxytocin Receptor Deficiency in Autism’
Jennifer Bartz, Mount Sinai Medical Center, USA: ‘Person- and context-dependent nature of oxytocin’s effects in humans and their therapeutic implications’
Coffee Break (10:15 – 10:45)
Keynote 4(10:45 – 11:30): Inga D. Neumann, University of Regensburg, Regensburg, Germany: ‘Brain oxytocin and vasopressin: mediators of stress, emotions and social behaviors’
Lunch Break(11:30 – 1:00)
Symposium 4(1:00 – 3:00): ‘Genetic Models for Neurohypophyseal Development and Function’
Organizer:
Gil Levkowitz,Weizmann Institute, Israel: ‘Development of the zebrafish hypothalamo-neurohypophyseal system’
Speakers:
Marysia Placzek, U Sheffield, UK: ‘FGFs in development and function of the infundibulum’
Jacques L. Michaud, McGill University, Canada: ‘Transcriptional regulation of anterior hypothalamic development’
Bassil Kublaoui, University of Pennsylvania, USA: ‘Oxytocin and the hypothalamic regulation of feeding’
Coffee Break (3:00 – 3:30)
Symposium 5(3:30 – 5:30):‘Clinical Use of Vasopressin Receptor Antagonists in Hyponatremia: The Science of Who We Should Treat, and Why’
Organizer:
Joseph Verbalis, Georgetown University, USA
Speakers:
Ron Wald, University of Toronto, Toronto, Canada: ‘Hospital-Associated Hyponatremia: Implications for Clinical Outcomes’
Yoshihisa Sugimura, Nagoya University Graduate School of Medicine, Nagoya, Japan: ‘Minocycline Prevents Osmotic Demyelination Syndrome by Inhibiting the Activation of Microglia’
Julia Barsony, Georgetown University, Washington, DC: ‘Hyponatremia-Induced Osteoporosis: Cellular Mechanisms’
Keynote 5 (5:30 – 6:00):Maurice Manning, The University of Toledo, Toledo, OH, USA:‘Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics’
Special Lecture (6:00 – 6:30):Claudio D. Schteingart, Ferring Research Institute, USA: ‘Discovery and characterization of a new selective oxytocin agonist for lactation support’
SATURDAY
Symposium 6(8:15 – 10:30): ‘The Hypothalamo-Neurohypophyseal System: from Genome to Physiology’
Organizer:
David Murphy, University of Bristol, UK
Speakers:
Jonathan Sweedler, University of Illinois, USA: ‘Neuropeptidomics of the suprachiasmatic nucleus: from discovery to function’
Agnieszka Konopacka, University of Bristol, UK: ‘Transcriptomics of the hypothalamo-neurohypophyseal system: from discovery to function’
Nina Japundzic Zigon, University of Belgrade, Serbia: ‘Use of adenoviruses to assess the role of PVN vasopressin receptors in the cardiovascular response to stress in conscious rats’
Yoichi Ueta, University of Occupational and Environmental Health, Kitakyushu, Japan: ‘Fluorescent visualization of vasopressin- and oxytocin neurons under physiological and pathophysiological conditions’
Valery Grinevich, Max-Planck-Institute for Medical Research, Heidelberg, Germany: ‘Using viral vector technology in probing axonal oxytocin release in the forebrain’
Coffee Break (10:30 – 11:00);
Keynote 6 (11:00 – 11:45): Harold Gainer, NINDS, Bethesda, MD, USA; ‘Cell-specific expression of oxytocin and vasopressin genes: An experimental odyssey’
Lunch Break (11:45 – 1:15)
Symposium 7 (1:15 – 3:15): ‘Glial Control of Magnocellular Neurons’
Organizer and Chair:
Colin Brown, University of Otago, New Zealand
Co-chair:
Jeff Tasker, Tulane University, USA
Speakers:
Jaideep Bains, University of Calgary, Canada: ‘Astrocytes and feedforward synaptic scaling’
Javier Stern, Medical College of Georgia, USA: ‘Tonic regulation of MNC activity via glial regulation of extrasynaptic signaling mechanisms’
Stéphane Oliet, Bordeaux Neurosciences Institute, Inserm, France: ‘Structural remodeling of the supraoptic nucleus in lactation: Consequences of neuron-glia interactions’
Posters and Wine (3:15 – 5:30)
Poster Session 2: Peripheral Mechanisms and Behavior
Osmoregulation, parturition, lactation, cardiovascular regulation, thermoregulation, gastro-intestinal regulation, bone formation; reproductive, maternal, aggressive, affiliative, ingestive, and other behaviors; behavioral disorders; pharmacology
Keynote 7 (5:30 – 6:15): Charles W. Bourque, McGill University, Montreal, QC, Canada; ‘Clock Neurons, glial cells and osmoregulated firing by vasopressin neurons’
Closing Ceremonies (Awards) and Banquet (7:00 – 11:00)
Program
PROGRAM OVERVIEW
KEYNOTE ADDRESSES AND SPECIAL LECTURES
SYMPOSIA
POSTER SESSIONS
Hypothalamo-neurohypophysial system, extra-hypothalamic systems, receptor mechanisms, stress, pain, neuroimmunology
Osmoregulation, parturition, lactation, cardiovascular regulation, thermoregulation, gastro-intestinal regulation, bone formation; reproductive, maternal, aggressive, affiliative, ingestive, and other behaviors; behavioral disorders; pharmacology
PROGRAM SCHEDULE
PROGRAM DETAILS
WEDNESDAY
THURSDAY
Organizer and Chair:
Larry Young, Emory University, USA
Speakers:
Ruth Feldman, Bar-Ilan University, Israel: ‘Oxytocin and affiliation in humans: Becoming a parent and falling in love’
René Hurlemann, University of Bonn, Germany: ‘Oxytocin closes gender gap in socially reinforced learning and emotional empathy’
Adam Guastella, University of Sydney: ‘Oxytocin and processing of social information in healthy and clinical population’
Organizer:
Heather Caldwell, Kent State U, USA
Speakers:
Michael Bowen, University of Sydney: ‘Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats’
Kimberly Young, Florida State University: ‘Oxytocin Reverses Amphetamine-Induced Social Deficits in the Monogamous Prairie Vole’
Benjamin F. Rood, Children’s Hospital of Philadelphia: ‘Vasopressin alters Post-Synaptic Current Activity in Serotonin Neurons of the Dorsal Raphe’
Katrina Choe, McGill University: ‘Salt-Loading reverses Chloride Gradient via Downregulation of KCC 2 In Rat Supraoptic Neurons’
Thekkethil P. Nedungadi, University of North Texas Health Science Center: ‘Expression and Regulation of TRPV2 in Rat Magnocellular Neurosecretory Cells’
Victoria Scott, University of Otago: ‘Hormonal Activation of Oxytocin and Vasopressin Neurons by Peripheral Kisspeptin’
Zoe Donaldson, Columbia University: ‘Microsatellite Regions upstream of the Vole Avpr1a Gene contribute to both Individual and Species Differences in Receptor Expression’
Sophie Knobloch, Max Planck Institute, Heidelberg: ‘Monosynaptic Connections of Oxytocin, but not Vasopressin Neurons in the Hypothalamus of Lactating Rats’
Posters and Wine (3:00 – 5:15)
Poster Session 1: Central Mechanisms
Hypothalamo-neurohypophysial system, extra-hypothalamic systems, receptor mechanisms, stress, pain, neuroimmunology
FRIDAY
Organizer:
Robert Ring, Pfizer, USA
Speakers:
David Feifel, UC San Diego, USA: ‘Oxytocin as a putative therapeutic agent for schizophrenia’
Simon Gregory, Duke U, USA: ‘Epigenetic Evidence of Oxytocin Receptor Deficiency in Autism’
Jennifer Bartz, Mount Sinai Medical Center, USA: ‘Person- and context-dependent nature of oxytocin’s effects in humans and their therapeutic implications’
Organizer:
Gil Levkowitz,Weizmann Institute, Israel: ‘Development of the zebrafish hypothalamo-neurohypophyseal system’
Speakers:
Marysia Placzek, U Sheffield, UK: ‘FGFs in development and function of the infundibulum’
Jacques L. Michaud, McGill University, Canada: ‘Transcriptional regulation of anterior hypothalamic development’
Bassil Kublaoui, University of Pennsylvania, USA: ‘Oxytocin and the hypothalamic regulation of feeding’
Organizer:
Joseph Verbalis, Georgetown University, USA
Speakers:
Ron Wald, University of Toronto, Toronto, Canada: ‘Hospital-Associated Hyponatremia: Implications for Clinical Outcomes’
Yoshihisa Sugimura, Nagoya University Graduate School of Medicine, Nagoya, Japan: ‘Minocycline Prevents Osmotic Demyelination Syndrome by Inhibiting the Activation of Microglia’
Julia Barsony, Georgetown University, Washington, DC: ‘Hyponatremia-Induced Osteoporosis: Cellular Mechanisms’
SATURDAY
Organizer:
David Murphy, University of Bristol, UK
Speakers:
Jonathan Sweedler, University of Illinois, USA: ‘Neuropeptidomics of the suprachiasmatic nucleus: from discovery to function’
Agnieszka Konopacka, University of Bristol, UK: ‘Transcriptomics of the hypothalamo-neurohypophyseal system: from discovery to function’
Nina Japundzic Zigon, University of Belgrade, Serbia: ‘Use of adenoviruses to assess the role of PVN vasopressin receptors in the cardiovascular response to stress in conscious rats’
Yoichi Ueta, University of Occupational and Environmental Health, Kitakyushu, Japan: ‘Fluorescent visualization of vasopressin- and oxytocin neurons under physiological and pathophysiological conditions’
Valery Grinevich, Max-Planck-Institute for Medical Research, Heidelberg, Germany: ‘Using viral vector technology in probing axonal oxytocin release in the forebrain’
Organizer and Chair:
Colin Brown, University of Otago, New Zealand
Co-chair:
Jeff Tasker, Tulane University, USA
Speakers:
Jaideep Bains, University of Calgary, Canada: ‘Astrocytes and feedforward synaptic scaling’
Javier Stern, Medical College of Georgia, USA: ‘Tonic regulation of MNC activity via glial regulation of extrasynaptic signaling mechanisms’
Stéphane Oliet, Bordeaux Neurosciences Institute, Inserm, France: ‘Structural remodeling of the supraoptic nucleus in lactation: Consequences of neuron-glia interactions’
Poster Session 2: Peripheral Mechanisms and Behavior
Osmoregulation, parturition, lactation, cardiovascular regulation, thermoregulation, gastro-intestinal regulation, bone formation; reproductive, maternal, aggressive, affiliative, ingestive, and other behaviors; behavioral disorders; pharmacology